Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...

Several biomarker tests have been available for over a decade, with extensive research backing their effectiveness. Yet, many urologists remain unaware of their full potential to streamline practice ...

Formula One team owner Eddie Jordan has died, aged 76, after a year-long battle with prostate and bladder cancer. The Irishman revealed in December he was suffering from bladder and prostate ...

Elevated circulating tumor DNA (ctDNA) fraction and tumor suppressor gene loss are associated with worse prognosis in patients with prostate cancer liver metastases (PCLM), accord ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

A retired engineer who has recovered from prostate cancer is urging men to get themselves tested for the disease. Keith Davies, 74, had a blood test at a charity event in 2020 which showed high ...

Get Instant Summarized Text (Gist) Monitoring PSA levels too soon after prostate cancer surgery can lead to unnecessary treatments. The standard practice of checking PSA levels one-and-a-half to ...